J. Lo

Endocrinology, Diabetes and Metabolism · Journal of the American Medical Association (JAMA) · 2004–2011

A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Lo trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. E. Ford

Papers from J. Lo's perspective

Ordered by how strongly the researchers J. Lo trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
  2. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. (American Journal of Epidemiology)
  3. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. (Journal of the American Medical Association (JAMA))
  4. Klotho converts canonical FGF receptor into a specific receptor for FGF23 (Nature)
  5. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. (Journal of the American Society of Nephrology)
  6. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. (American Journal of Kidney Diseases)
  7. Metformin reverses fatty liver disease in obese, leptin-deficient mice (Nature Medicine)
  8. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. (New England Journal of Medicine)
  9. Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)
  10. The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin (Science)

Their papers